MoneyWorks4Me

Concord Drugs - Quaterly Results

08 Aug 2025 Evaluate
The total revenue hovered 110.67% to Rs. 133.84 millions for the June 2025 quarter as against Rs. 63.53 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 833.33% to Rs. 1.12  millions from Rs. 0.12 millions in the previous quarter.Operating profit surged to 9.39 millions from the corresponding previous quarter of 7.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 133.84 63.53 110.67 133.84 63.53 110.67 369.46 432.70 -14.62
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 9.39 7.32 28.28 9.39 7.32 28.28 37.77 36.87 2.44
Interest 4.20 3.70 13.51 4.20 3.70 13.51 17.18 15.90 8.05
PBDT 5.19 3.62 43.37 5.19 3.62 43.37 20.59 20.97 -1.81
Depreciation 3.66 3.35 9.25 3.66 3.35 9.25 14.18 15.38 -7.80
PBT 1.53 0.27 466.67 1.53 0.27 466.67 6.41 5.59 14.67
TAX 0.41 0.15 173.33 0.41 0.15 173.33 3.46 1.39 148.92
Deferred Tax -0.11 -0.09 22.22 -0.11 -0.09 22.22 1.56 -0.63 -347.62
PAT 1.12 0.12 833.33 1.12 0.12 833.33 2.95 4.20 -29.76
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 7.02 11.52 -39.11 7.02 11.52 -39.11 10.22 8.52 19.98
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..